These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 27461846

  • 1. Pharmacokinetics and Safety of Tedizolid after Single and Multiple Intravenous/Oral Sequential Administrations in Healthy Chinese Subjects.
    Chen R, Shen K, Chang X, Tanaka T, Li L, Hu P.
    Clin Ther; 2016 Aug; 38(8):1869-79. PubMed ID: 27461846
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male Subjects.
    Kim Y, Kim A, Lee S, Choi SH, Lee DY, Song JS, Lee H, Jang IJ, Yu KS.
    Clin Ther; 2017 Sep; 39(9):1849-1857. PubMed ID: 28865799
    [Abstract] [Full Text] [Related]

  • 3. Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid.
    Flanagan S, Fang E, Muñoz KA, Minassian SL, Prokocimer PG.
    Pharmacotherapy; 2014 Sep; 34(9):891-900. PubMed ID: 24989138
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.
    Bradley JS, Flanagan SD, Arrieta AC, Jacobs R, Capparelli E, Prokocimer P.
    Pediatr Infect Dis J; 2016 Jun; 35(6):628-33. PubMed ID: 26910588
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrug.
    Flanagan SD, Bien PA, Muñoz KA, Minassian SL, Prokocimer PG.
    Pharmacotherapy; 2014 Mar; 34(3):240-50. PubMed ID: 23926058
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate in Elderly Subjects.
    Flanagan SD, Minassian SL, Prokocimer P.
    Clin Pharmacol Drug Dev; 2018 Sep; 7(7):788-794. PubMed ID: 29319932
    [Abstract] [Full Text] [Related]

  • 7. Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.
    Guo B, Wu X, Zhang Y, Shi Y, Yu J, Cao G, Zhang J.
    Clin Drug Investig; 2012 Jul 01; 32(7):475-86. PubMed ID: 22650326
    [Abstract] [Full Text] [Related]

  • 8. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG, Love R, Adam H, Golden A, Zelenitsky S, Schweizer F, Gorityala B, Lagacé-Wiens PR, Rubinstein E, Walkty A, Gin AS, Gilmour M, Hoban DJ, Lynch JP, Karlowsky JA.
    Drugs; 2015 Feb 01; 75(3):253-70. PubMed ID: 25673021
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and Safety of Single-dose Tedizolid Phosphate in Children 2 to <12 Years of Age.
    Arrieta AC, Ang JY, Espinosa C, Fofanov O, Tøndel C, Chou MZ, De Anda CS, Kim JY, Li D, Sabato P, Sears PS, Bradley JS.
    Pediatr Infect Dis J; 2021 Apr 01; 40(4):317-323. PubMed ID: 33710976
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment.
    Flanagan S, Minassian SL, Morris D, Ponnuraj R, Marbury TC, Alcorn HW, Fang E, Prokocimer P.
    Antimicrob Agents Chemother; 2014 Nov 01; 58(11):6471-6. PubMed ID: 25136024
    [Abstract] [Full Text] [Related]

  • 11. Effects of therapeutic and supratherapeutic doses of oral tedizolid phosphate on cardiac repolarisation in healthy volunteers: a randomised controlled study.
    Flanagan S, Litwin J, Fang E, Prokocimer P.
    Int J Antimicrob Agents; 2016 Jul 01; 48(1):33-40. PubMed ID: 27342387
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the haematological profile of 21 days of tedizolid in healthy subjects.
    Lodise TP, Bidell MR, Flanagan SD, Zasowski EJ, Minassian SL, Prokocimer P.
    J Antimicrob Chemother; 2016 Sep 01; 71(9):2553-8. PubMed ID: 27317442
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and tolerability of intravenous ibuprofen injection in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study
.
    Zhou H, Xu W, Wu G, Wu L, Shentu J, Pan Z, Hu S, Liu Y.
    Int J Clin Pharmacol Ther; 2016 Nov 01; 54(11):904-913. PubMed ID: 27569737
    [Abstract] [Full Text] [Related]

  • 14. Tolerability and Pharmacokinetic Comparison of Oral, Intramuscular, and Intravenous Administration of Levosulpiride After Single and Multiple Dosing in Healthy Chinese Volunteers.
    Xu M, Zhou Y, Ni Y, He X, Li H, Sattar H, Chen H, Li W.
    Clin Ther; 2015 Nov 01; 37(11):2458-67. PubMed ID: 26404395
    [Abstract] [Full Text] [Related]

  • 15. Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infections.
    Hardalo C, Lodise TP, Bidell M, Flanagan S, De Anda C, Anuskiewicz S, Prokocimer P.
    Expert Opin Drug Saf; 2018 Apr 01; 17(4):359-367. PubMed ID: 29528251
    [Abstract] [Full Text] [Related]

  • 16. Single-dose Intravenous Safety, Tolerability, and Pharmacokinetics and Absolute Bioavailability of LCB01-0371.
    Cho YS, Lim HS, Han S, Yoon SK, Kim H, Cho YL, Nam HS, Bae KS.
    Clin Ther; 2019 Jan 01; 41(1):92-106. PubMed ID: 30559004
    [Abstract] [Full Text] [Related]

  • 17. Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate.
    Ong V, Flanagan S, Fang E, Dreskin HJ, Locke JB, Bartizal K, Prokocimer P.
    Drug Metab Dispos; 2014 Aug 01; 42(8):1275-84. PubMed ID: 24875463
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
    Wu H, Liu M, Wang S, Feng W, Yao W, Zhao H, Wei M.
    Clin Ther; 2010 Mar 01; 32(3):597-606. PubMed ID: 20399996
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.